This announcement is a separate document:
广济药业：2022年第一季度报告全文（更正后）
Guangji Pharmaceutical: Full report for the first quarter of 2022 (after correction)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.